Show simple item record

dc.contributor.advisorGroutas, William C.en
dc.contributor.authorDou, Dengfeng
dc.date.accessioned2010-11-30T16:21:24Z
dc.date.available2010-11-30T16:21:24Z
dc.date.copyright2010
dc.date.issued2010-05
dc.identifier.otherd10003
dc.identifier.urihttp://hdl.handle.net/10057/3281
dc.descriptionThesis (Ph.D.)--Wichita State University, College of Liberal Arts and Sciences, Dept. of Chemistryen
dc.description.abstractChronic Obstructive Pulmonary Disease (COPD) is currently the fourth leading cause of death in the US. COPD is a multi-factorial disorder characterized by an oxidant/antioxidant imbalance, inflammation, a protease/antiprotease imbalance and apoptosis. This dissertation describes a general strategy for the design, synthesis and biochemical evaluation of dual function inhibitors which could potentially interrupt the above disorder, thereby enhancing the treatment of COPD. An example of this type inhibitor based on the 1,2,5-thiadiazolidin-3-one scaffold has been proven effective against both human neutrophil elastase (HNE) and caspase-1, two key enzymes responsible for elastin degradation and inflammation, respectively. In addition, an X-ray crystal structure and a high resolution mass spectrum of inhibitor bonded HNE have proven the proposed mechanism of HNE inactivation. Furhtermore, simple reversible competitive inhibitors of COPD-related enzymes (HNE and proteinase 3) have also been designed, synthesized and evaluated biochemically. West Nile virus and Dengue virus are recognized as a major health threat that affects millions of people worldwide. However, there is currently no treatment or vaccine available for the virus infection. This dissertation describes the design, synthesis and biochemical evaluation of reversible competitive inhibitors of both West Nile virus and Dengue virus NS2B-NS3 protease. Combinatorial chemistry and click chemistry methods have been used in the design of the protease inhibitor and the identified hit was optimized using computational programs (AutoDock4 and SYBYL). Several more hits were identified during the optimization and further development could potentially lead to very potent inhibitors of NS2B-NS3 protease with good pharmacokinetics and oral bioavailability.en
dc.format.extentxvii, 220 p.en
dc.format.extent3772624 bytes
dc.format.extent1843 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_USen
dc.publisherWichita State Universityen
dc.rightsCopyright Dengfeng Dou, 2010. All rights reserveden
dc.subject.lcshElectronic dissertationsen
dc.titleMammalian and viral protease inhibitorsen
dc.typeDissertationen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record